{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:27:16Z","timestamp":1792189636836,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-12969"],"award-info":[{"award-number":["IG-12969"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ferritin is a nanocage protein composed by the variable assembly of 24 heavy and light subunits. As major intracellular iron storage protein, ferritin has been studied for many years in the context of iron metabolism. However, recent evidences have highlighted its role, in particular that of the heavy subunit (FHC), in pathways related to cancer development and progression, such as cell proliferation, growth suppressor evasion, cell death inhibition, and angiogenesis. At least partly, the involvement in these pathways is due to the ability of FHC to control the expression of a repertoire of oncogenes and oncomiRNAs. Moreover, the existence of a feedback loop between FHC and the tumor suppressor p53 has been demonstrated in different cell types. Here, we show that ectopic over-expression of FHC induces the promoter hypermethylation and the down-regulation of miR-125b that, in turn, enhances p53 protein expression in non-small cell lung cancer (NSCLC) cell lines. Notably, analysis by absolute quantitative RT-PCR of <jats:italic>FHC<\/jats:italic>, <jats:italic>miR-125b,<\/jats:italic> and <jats:italic>p53<\/jats:italic> strongly suggests that this axis might be active in human NSCLC tissue specimens. In vitro, FHC over-expression attenuates survival of NSCLC cells by inducing p53-mediated intrinsic apoptosis that is partially abrogated upon miR-125b re-expression. Overall, our findings demonstrate that FHC acts as a tumor suppressor gene, thus providing a potential molecular strategy for induction of NSCLC apoptotic cell death.<\/jats:p>","DOI":"10.1038\/s41419-018-1216-3","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T10:19:48Z","timestamp":1544005188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b\/p53 axis"],"prefix":"10.1038","volume":"9","author":[{"given":"Flavia","family":"Biamonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Martina","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Zolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-3060","authenticated-orcid":false,"given":"Duarte Mendes","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-7492","authenticated-orcid":false,"given":"Gianluca","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia Dora","family":"Giovannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"1216_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E. & Adjei, A. A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 83, 584\u2013594 (2008).","journal-title":"Mayo Clin. Proc."},{"key":"1216_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","volume":"5","author":"C Zappa","year":"2016","unstructured":"Zappa, C. & Mousa, S. A. Non-small cell lung cancer: current treatment and future advances. Transl. Lung Cancer Res. 5, 288\u2013300 (2016).","journal-title":"Transl. Lung Cancer Res."},{"key":"1216_CR3","first-page":"479","volume":"5","author":"WA Cooper","year":"2013","unstructured":"Cooper, W. A., Lam, D. C., O'Toole, S. A. & Minna, J. D. Molecular biology of lung cancer. J. Thorac. Dis. 5, 479\u2013490 (2013).","journal-title":"J. Thorac. Dis."},{"key":"1216_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-13-0539","volume":"12","author":"DL Gibbons","year":"2014","unstructured":"Gibbons, D. L., Byers, L. A. & Kurie, J. M. Smoking, p53 mutation, and lung cancer. Mol. Cancer Res. 12, 3\u201313 (2014).","journal-title":"Mol. Cancer Res."},{"key":"1216_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","volume":"14","author":"KT Bieging","year":"2014","unstructured":"Bieging, K. T., Mello, S. S. & Attardi, L. D. Unravelling mechanisms of p53-mediated tumour suppression. Nat. Rev. Cancer 14, 359\u2013370 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"1216_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden, K. H. & Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275\u2013283 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1089\/ars.2010.3644","volume":"15","author":"D Liu","year":"2011","unstructured":"Liu, D. & Xu, Y. p53, oxidative stress, and aging. Antioxid. Redox Signal. 15, 1669\u20131678 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1089\/ars.2011.4434","volume":"16","author":"A Maillet","year":"2012","unstructured":"Maillet, A. & Pervaiz, S. Redox regulation ofp53, redox effectors regulated by p53: a subtle balance. Antioxid. Redox Signal. 16, 1285\u20131294 (2012).","journal-title":"Antioxid. Redox Signal."},{"key":"1216_CR9","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman, J. S. & Lowe, S. W. Control of apoptosis by p53. Oncogene 22, 9030\u20139040 (2003).","journal-title":"Oncogene"},{"key":"1216_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00690207","volume":"14","author":"MB Kastan","year":"1995","unstructured":"Kastan, M. B., Canman, C. E. & Leonard, C. J. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis. Rev. 14, 3\u201315 (1995).","journal-title":"Cancer Metastasis. Rev."},{"key":"1216_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","volume":"137","author":"JP Kruse","year":"2009","unstructured":"Kruse, J. P. & Gu, W. Modes of p53 regulation. Cell 137, 609\u2013622 (2009).","journal-title":"Cell"},{"key":"1216_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/138920209788185270","volume":"10","author":"A Takwi","year":"2009","unstructured":"Takwi, A. & Li, Y. The p53 pathway encounters the microRNA world. Curr. Genomics 10, 194\u2013197 (2009).","journal-title":"Curr. Genomics"},{"key":"1216_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jmcb\/mjq040","volume":"3","author":"Z Feng","year":"2011","unstructured":"Feng, Z., Zhang, C., Wu, R. & Hu, W. Tumor suppressor p53 meets microRNAs. J. Mol. Cell Biol. 3, 44\u201350 (2011).","journal-title":"J. Mol. Cell Biol."},{"key":"1216_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jcb.25609","volume":"118","author":"J Liu","year":"2017","unstructured":"Liu, J., Zhang, C., Zhao, Y. & Feng, Z. MicroRNA control of p53. J. Cell Biochem. 118, 7\u201314 (2017).","journal-title":"J. Cell Biochem."},{"key":"1216_CR15","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1128\/MCB.23.23.8576-8585.2003","volume":"23","author":"S Macip","year":"2003","unstructured":"Macip, S. et al. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell Biol. 23, 8576\u20138585 (2003).","journal-title":"Mol. Cell Biol."},{"key":"1216_CR16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.freeradbiomed.2008.01.011","volume":"44","author":"B Liu","year":"2008","unstructured":"Liu, B., Chen, Y. & St Clair, D. K. ROS andp53: a versatile partnership. Free Radic. Biol. Med. 44, 1529\u20131535 (2008).","journal-title":"Free Radic. Biol. Med."},{"key":"1216_CR17","doi-asserted-by":"publisher","first-page":"146514","DOI":"10.1038\/cdd.2013.52","volume":"20","author":"J Montero","year":"2013","unstructured":"Montero, J., Dutta, C., van Bodegom, D., Weinstock, D. & Letai, A. p53 regulates a non-apoptotic death induced by ROS. Cell Death Differ. 20, 146514\u2013146574 (2013).","journal-title":"Cell Death Differ."},{"key":"1216_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/bj3570241","volume":"357","author":"K Orino","year":"2001","unstructured":"Orino, K. et al. Ferritin and the response to oxidative stress. Biochem. J. 357, 241\u2013247 (2001).","journal-title":"Biochem. J."},{"key":"1216_CR19","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","volume":"99","author":"FM Torti","year":"2002","unstructured":"Torti, F. M. & Torti, S. V. Regulation of ferritin genes and protein. Blood 99, 3505\u20133516 (2002).","journal-title":"Blood"},{"key":"1216_CR20","first-page":"155","volume":"7","author":"BS Min Pang","year":"2015","unstructured":"Min Pang, B. S. & Connor, J. R. Role of ferritin in cancer biology. J. Cancer Sci. Ther. 7, 155\u2013160 (2015).","journal-title":"J. Cancer Sci. Ther."},{"key":"1216_CR21","doi-asserted-by":"publisher","first-page":"33911","DOI":"10.1074\/jbc.M806432200","volume":"283","author":"F Zhang","year":"2008","unstructured":"Zhang, F., Wang, W., Tsuji, Y., Torti, S. V. & Torti, F. M. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J. Biol. Chem. 283, 33911\u201333918 (2008).","journal-title":"J. Biol. Chem."},{"key":"1216_CR22","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.biocel.2008.02.010","volume":"40","author":"MC Faniello","year":"2008","unstructured":"Faniello, M. C. et al. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y. Int. J. Biochem. Cell Biol. 40, 2110\u20132119 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bbrc.2009.08.125","volume":"389","author":"JH Lee","year":"2009","unstructured":"Lee, J. H., Jang, H., Cho, E. J. & Youn, H. D. Ferritin binds and activates p53 under oxidative stress. Biochem. Biophys. Res. Commun. 389, 399\u2013404 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1216_CR24","doi-asserted-by":"publisher","first-page":"e0163078","DOI":"10.1371\/journal.pone.0163078","volume":"11","author":"F Zolea","year":"2016","unstructured":"Zolea, F. et al. Caffeine positively modulates ferritin heavy chain expression in H460 cells: effects on cell proliferation. PLoS ONE 11, e0163078 (2016).","journal-title":"PLoS ONE"},{"key":"1216_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1101\/gad.1767609","volume":"23","author":"MT Le","year":"2009","unstructured":"Le, M. T. et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862\u2013876 (2009).","journal-title":"Genes Dev."},{"key":"1216_CR26","doi-asserted-by":"publisher","first-page":"e0122105","DOI":"10.1371\/journal.pone.0122105","volume":"10","author":"F Biamonte","year":"2015","unstructured":"Biamonte, F. et al. H-ferritin-regulated microRNAs modulate gene expression in K562 cells. PLoS ONE 10, e0122105 (2015).","journal-title":"PLoS ONE"},{"key":"1216_CR27","doi-asserted-by":"publisher","first-page":"62019","DOI":"10.18632\/oncotarget.11495","volume":"7","author":"N Lobello","year":"2016","unstructured":"Lobello, N. et al. Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. Oncotarget 7, 62019\u201362033 (2016).","journal-title":"Oncotarget"},{"key":"1216_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1600-0625.2011.01359.x","volume":"20","author":"S Manca","year":"2011","unstructured":"Manca, S. et al. Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Exp. Dermatol. 20, 932\u2013937 (2011).","journal-title":"Exp. Dermatol."},{"key":"1216_CR29","doi-asserted-by":"crossref","unstructured":"Chen, H. & Xu, Z. Hypermethylation-associated Silencing of miR-125a and miR-125b: a potential marker in colorectal cancer. Dis. Markers 2015, 345080 (2015).","DOI":"10.1155\/2015\/345080"},{"key":"1216_CR30","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1158\/0008-5472.CAN-10-2435","volume":"71","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res. 71, 3552\u20133562 (2011).","journal-title":"Cancer Res."},{"key":"1216_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti, S. V. & Torti, F. M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13, 342\u2013355 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1216_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13238-014-0119-z","volume":"6","author":"C Zhang","year":"2015","unstructured":"Zhang, C. & Zhan, F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell 6, 88\u2013100 (2015).","journal-title":"Protein Cell"},{"key":"1216_CR33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2353\/ajpath.2010.090249","volume":"176","author":"P Dongiovanni","year":"2010","unstructured":"Dongiovanni, P. et al. Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Am. J. Pathol. 176, 1006\u20131017 (2010).","journal-title":"Am. J. Pathol."},{"issue":"1","key":"1216_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.celrep.2014.02.042","volume":"7","author":"Jia Shen","year":"2014","unstructured":"Shen, J. et al. Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function. Cell Rep. 7, 180\u2013193 (2014).","journal-title":"Cell Reports"},{"key":"1216_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep16497","volume":"5","author":"Y Funauchi","year":"2015","unstructured":"Funauchi, Y. et al. Regulation of iron homeostasis by the p53-ISCU pathway. Sci. Rep. 5, 16497 (2015).","journal-title":"Sci. Rep."},{"key":"1216_CR36","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.freeradbiomed.2010.02.019","volume":"48","author":"N Bresgen","year":"2010","unstructured":"Bresgen, N. et al. Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death. Free Radic. Biol. Med. 48, 1347\u20131357 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"1216_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar3377","volume":"13","author":"A Ceribelli","year":"2011","unstructured":"Ceribelli, A. et al. MicroRNAs in systemic rheumatic diseases. Arthritis Res. Ther. 13, 229 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"1216_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrrheum.2012.142","volume":"8","author":"N Shen","year":"2012","unstructured":"Shen, N., Liang, D., Tang, Y., de Vries, N. & Tak, P. P. MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis. Nat. Rev. Rheumatol. 8, 701\u2013709 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1216_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/cdd.2017.174","volume":"25","author":"KD Sullivan","year":"2018","unstructured":"Sullivan, K. D., Galbraith, M. D., Andrysik, Z. & Espinosa, J. M. Mechanisms of transcriptional regulation by p53. Cell Death Differ. 25, 133\u2013143 (2018).","journal-title":"Cell Death Differ."},{"key":"1216_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J. & Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 25, 104\u2013113 (2018).","journal-title":"Cell Death Differ."},{"key":"1216_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495\u2013516 (2007).","journal-title":"Toxicol. Pathol."},{"key":"1216_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13046-017-0571-8","volume":"36","author":"I Aversa","year":"2017","unstructured":"Aversa, I. et al. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4\/CXCL12 axis. J. Exp. Clin. Cancer Res. 36, 104 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1216_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.freeradbiomed.2015.07.161","volume":"89","author":"F Zolea","year":"2015","unstructured":"Zolea, F. et al. H ferritin silencing induces protein misfolding in K562 cells: a Raman analysis. Free Radic. Biol. Med. 89, 614\u2013623 (2015).","journal-title":"Free Radic. Biol. Med."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1216-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1216-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1216-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:05:20Z","timestamp":1672671920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1216-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1216-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1174"}}